Glaxosmi. Pharma (GLAXO) Share News & Alerts
Every article that mentions GLAXO is analysed by our AI, which assigns a sentiment and tracks the actual price move after the alert fires.
GSK Pharma gains as Q4 PAT rises 6% YoY to Rs 275 cr
▲ Bullish +1.76%
The stock is impacted by a steady Q4 earnings performance featuring a 6% profit increase and significant EBITDA margin expansion to 35.3%. The announcement of a large dividend (Rs 57/share) acts as a strong yield support for positional investors, though the modest 2% revenue growth may limit immediate aggressive upside. Over a swing timeframe of 1-2 weeks, the stock is likely to remain resilient as investors price in the high dividend payout and oncology segment traction.
GSK Pharma Q4 PAT rises 6% YoY to Rs 275 cr
▲ Bullish +2.09%
The steady 6% profit growth coupled with a significant dividend payout of Rs 57 per share acts as a strong yield support for the stock. In a sideways or volatile market, such high-dividend announcements often lead to re-rating and attract positional buyers looking for safety and income. Expect a bullish bias over the next few weeks as investors lock in the dividend yield.
Get real-time alerts for GLAXO
Add GLAXO to your portfolio and receive instant AI-powered news alerts on your phone.
Set up free alerts →Explore More
AI Technical Analysis Alert History Other Bullish Stocks Today’s Trending